The HAPLN3 variant appeared to act as a modifier in Arg4810Lys carriers by increasing tube formation and VEGF expression in endothelial cells, thereby contributing to the incomplete penetrance of MMD [194]. The gene discussed is HAPLN3; the disease is multiminicore myopathy.